Financials

News Ideas Discussions Technicals Forecast Seasonals

CSBTF fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Kuros Bioscience Ltd. operating, investing, and financing activities

CSBTF free cash flow for H2 24 is 3.26 M USD. For 2024, CSBTF free cash flow was 2.25 M USD and operating cash flow was 3.46 M USD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—